Nautilus Biotechnology, Inc. (NAUT) Tops Q4 EPS by 3c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q4 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• FOMC minutes from July 28-29th meeting
• TJX stock drops as profit outlook falls short of analyst estimates
• FDA approves Regeneron's Pasatru for rare bone disorder FOP